<DOC>
	<DOCNO>NCT01997788</DOCNO>
	<brief_summary>To evaluate efficacy safety intrathecal morphine injection open nephrectomy .</brief_summary>
	<brief_title>The Intrathecal Morphine Nephrectomy</brief_title>
	<detailed_description>The open nephrectomy treatment choice live donor kidney transplantation renal cell carcinoma . The incision nephrectomy cause severe postoperative pain . A single dose intrathecal morphine ( ITM ) use postoperative pain prostatectomy , transurethral resection prostate hepatectomy . The effect ITM open nephrectomy study . Therefore , prospective , randomize study evaluate efficacy safety single 50 mcg dose ITM add intravenous patient control analgesia ( IV-PCA ) , compare IV-PCA alone .</detailed_description>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Meperidine</mesh_term>
	<criteria>Patients schedule open nephrectomy Patients renal insufficiency Patients coagulopathy History neurologic disorder History recent infection 2 week History drug abuse Patients understand usage th intravenous patientcontrolled analgesia Patients use opioids due chronic pain</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Injection , Spinal</keyword>
	<keyword>Morphine</keyword>
	<keyword>Analgesia</keyword>
	<keyword>Patient-Controlled</keyword>
	<keyword>Pain</keyword>
	<keyword>Postoperative</keyword>
	<keyword>Combined Modality Therapy</keyword>
	<keyword>Nephrectomy</keyword>
</DOC>